Insurance Advisory Service November 2022—Segregated Fund Sales: From Renaissance to Respite
Products providing market exposure had, in general, a banner year in 2021. Segregated funds reached net sales volumes last year that were higher than at any time in the previous decade.
For 2022, different from mutual funds and ETFs, segregated funds traversed a path of their own, with relatively high net flows through the end of Q1, only to witness volumes decline progressively in following months.
The November research feature of the Insurance Advisory Service presents a review of segregated fund industry sales for year-to-date 2022.